We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Renal Cell Carcinoma
Center of Excellence
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Bruno Santucci
Apr 26, 2019
In my opinion if the patient is not symptomatic and the nodules are stable I would continue the treatment and re-evaluate every 10-12 weeks.
Laszlo Torday
Apr 26, 2019
This case cannot be discussed properly, because lots of information is missing. Patient had multiple splenic lesions and retroperitoneal lymph nodes and underwent radical nephrectomy with splenectomy. No data provided the pathological findings of surgical specimen regarding those splenic lesions. No proper data provided regarding measurements of proposed retroperitoeal lympadenopathy before the radical nephrectomy and on the latest scans, so we can't judge size changes of these lesions. We do not have the result of preoperative chest CT scan too, so we can't judge whether pulmonary nodules are novel lesions or not. It would be also useful to know, how many nodules are we talking about? 5? 10? or more? Without these data nobody can exactly asses the change of the disease, so no recommendation can be done regarding the further management.
Apr 24, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
JoAnn
Hsu
Bruno Santucci
Apr 26, 2019
Laszlo Torday
Apr 26, 2019
Apr 24, 2024
Pending Moderator approval.